Peripheral Arterial Disease (PAD) is the blockage of arteries outside of the heart and brain. PAD can severely affect an individual’s quality of life, and increase risk of life-threatening health conditions, such as heart attack and stroke.
A major sign of PAD is claudication, which involves fatigue, heaviness, tiredness, and cramping in the leg muscles that occurs during activities such as walking or climbing stairs. The main risk factors of PAD include smoking, high cholesterol, high blood pressure and diabetes.
PAD is detected through the use of an ankle brachial index (ABI) or ultrasound device that checks the blood pressure in your leg and arm. Once diagnosed, the severity of the disease must be determined to develop a proper treatment plan. The earlier the disease is caught, the easier it is to treat. The first line of treatment usually involves medical therapy that focuses on risk factor modification to reduce cardiovascular events, improve quality of life and survival.
The second line of treatment involves minimally invasive strategies such as balloon angioplasty and stenting, and atherectomy. The third line of treatment involves surgical bypass of the arteries in the leg (or arm).
The exceptional team of vascular surgeons and cardiologists within the Cone Health network are now performing advanced, combined endovascular and surgical procedures to treat PAD in the new hybrid operating room in Cone Health’s North Tower.
Hybrid operating rooms facilitate procedures through advanced visualization, allowing the medical team to perform minimally invasive, intricate endovascular and heart procedures all in one setting.
Dr. Jonathan Berry is a cardiologist at Southeastern Heart and Vascular Center and the cardiovascular section chief and medical director of the peripheral vascular lab at Cone Health. Dr. Berry is a 1983 graduate of University of Pennsylvania School of Medicine, completing his residency in internal medicine at Duke University Medical Center. He specializes in interventional cardiology and peripheral vascular disease, completing fellowships at both Duke University Medical Center and University of Michigan Hospitals. Dr. Berry also serves as a clinical professor at UNC Chapel Hill School of Medicine.